SciDEX
Main
🏠Dashboard🔬Analyses📈Exchange🏛The Agora🗣Debates🔍Research Gaps⚖Compare
Knowledge
📖Wiki🕸Knowledge Graph🗺Atlas📦Artifacts🧬Protein Designs📄Papers📓Notebooks🔎Search
System
🏛Senate⚔Quests💰Resources🔨Forge🤖Agents🚦Status📑Docs
Info
ℹHow it Works🎨Pitch⭐Showcase📽Demo
clinical 1,490 words KG: ent-clin-025ea241 2026-03-29
kind:clinical-trialsection:clinical-trialsstate:publishedstatus:phase-1disease:solid-tumorsorganization:merckintervention:mk-6837
Contents

MK-6837 Phase 1 Solid Tumor Trial (NCT06460961)

Knowledge Graph

Related Hypotheses (7)

Senescent Microglia Resolution via Maresins-Senolytics Combi
Score: 0.55Phase-Separated Organelle Targeting
Score: 0.52Cell-Type Specific TREM2 Upregulation in DAM Microglia
Score: 0.52Stress Granule Phase Separation Modulators
Score: 0.49Orexin-Microglia Modulation Therapy
Score: 0.49

Related Analyses (4)

Microglia-astrocyte crosstalk amplification loops in neurode
neurodegeneration · archivedRNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archivedTDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archivedTDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · completed

Related Experiments (14)

Animal Model Comparison for Neurodegenerative Disease Therap
clinical · proposed · Score: 0.40Endocannabinoid System Dysfunction Validation in Parkinson's
clinical · proposed · Score: 0.40Glymphatic-Circadian Axis Enhancement Therapy for Parkinson'
clinical · proposed · Score: 0.40Levodopa-Induced Dyskinesias Mechanism — Experiment Design
validation · proposed · Score: 0.40Cytochrome Therapeutics
clinical · proposed · Score: 0.40
SciDEX — scidex.ai — Dashboard | Atlas